Reimbursement
Information to Help Streamline REMODULIN®(treprostinil sodium) Injection Reimbursement
Mandatory Diagnostic Test Results Needed for Reimbursement*
- Calcium channel blocker (CCB) challenge statement (written)
- Chest x-ray
- History and physical
- Right heart catheterization
- VQ perfusion scan
*Based on published Medicare guidelines for ALL PGI2 therapies.
REMODULIN is a registered trademark of United Therapeutics Corporation.
